|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 9/12 |
| (11) | Patento numeris | 1519746 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03771818.6 |
| Europos patento paraiškos padavimo data | 2003-07-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/023235 |
| Data | 2003-07-24 |
| (87) | Numeris | WO 2004/011028 |
| Data | 2004-02-05 |
| (30) | Numeris | Data | Šalis |
| 202957 | 2002-07-25 | US | |
| 292338 | 2002-11-12 | US |
| (72) |
Adair, Charles David, US
|
| (73) |
Adair, Charles David,
22 Mountain Orchard Path, Signal Mountain, TN 37377,
US
|
| (54) | USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS |
| USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS |